US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Enliven Treateutics

59.01

+1.151.99%

Post-market: 59.010.00000.00%19:30 EDT

Volume:609.97K

Turnover:35.80M

Market Cap:4.32B

PE:-35.22

High:60.55

Open:58.36

Low:57.36

Close:57.86

52wk High:62.32

52wk Low:14.79

Shares:73.27M

Float Shares:61.73M

Volume Ratio:0.74

T/O Rate:0.99%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-1.6753

EPS(LYR):-1.8300

ROE:-15.31%

ROA:-11.00%

PB:4.83

PE(LYR):-32.25

Loading ...

Overview Company News Filings

U.S. RESEARCH ROUNDUP- Apple, Lennar, Toll Brothers

Enliven initiated with a Buy at Stifel

Mizuho Securities Sticks to Their Buy Rating for Enliven Therapeutics (ELVN)

Enliven Therapeutics presents at TD Cowen oncology summit fireside chat

Enliven CMO Helen Louise Collins sells USD 191,757 in common shares

Analysts Are Bullish on Top Healthcare Stocks: Molecular Partners (MOLN), Enliven Therapeutics (ELVN)

Enliven to presents Phase 1 clinical trial data for ELVN-100 at EHA Congress

Stock Track | Enliven Therapeutics Soars 5.35% on Positive Clinical Data, Analyst Initiation, and Earnings Beat

Enliven presents updated Phase 1 ELVN-001 data in CML at EHA 2026

Enliven Therapeutics Announces Oral Presentation at the Eha 2026 Congress Featuring Additional Positive Phase 1 Clinical Trial Data for Elvn-001 in Cml

THOMSON REUTERS

Enliven Therapeutics Inc reports results for the quarter ended March 31 - Earnings Summary

U.S. RESEARCH ROUNDUP-Accuray, Aevex, Zoetis

Enliven Therapeutics Inc : Guggenheim Initiates Coverage With Buy Rating; Target Price $80

THOMSON REUTERS

Enliven initiated with a Buy at Guggenheim

Enliven price target raised to $59 from $41 at Goldman Sachs

Phil Nadeau Reiterates Buy on Enliven, Citing Strong ELVN-001 Early Data, Clear Pivotal Path, and Solid Cash Runway to 2029

Needham’s Boris Peaker Reiterates Buy on Enliven, Citing Strong ELVN-001 Efficacy in CML and Pivotal Phase 3 ENABLE-2 Catalyst Pathway

Enliven Therapeutics Q1 net loss narrows as R&D spending reduces

Enliven Q1 FY26 net loss narrows to $23.6 million###

Press Release: Enliven Therapeutics Reports First Quarter Financial Results and Provides a Business Update

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://au1.tigerplaytime.com/stock/ELVN/news?page=4"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ELVN","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ELVN\",,,,,undefined,":{"symbol":"ELVN","market":"US","secType":"STK","nameCN":"Enliven Treateutics","latestPrice":59.01,"timestamp":1788379200000,"preClose":57.86,"halted":0,"volume":609969,"hourTrading":{"tag":"盘后","latestPrice":59.01,"preClose":59.01,"latestTime":"19:30 EDT","volume":7266,"amount":428769.02,"timestamp":1788391806636,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.019875561700656734,"floatShares":61725902,"shares":73270761,"eps":-1.67535,"marketStatus":"Not Yet Opened","change":1.15,"latestTime":"09-02 16:00:00 EDT","open":58.36,"high":60.55,"low":57.36,"amount":35803975.611225,"amplitude":0.055133,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.67535,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1788422400000},"marketStatusCode":0,"adr":0,"listingDate":1583985600000,"exchange":"NASDAQ","adjPreClose":57.86,"preHourTrading":{"tag":"盘前","latestPrice":58.5,"preClose":57.86,"latestTime":"09:28 EDT","volume":946,"amount":54874.39496,"timestamp":1788355680094,"change":0.64,"changeRate":0.011061,"amplitude":0.082786},"postHourTrading":{"tag":"盘后","latestPrice":59.01,"preClose":59.01,"latestTime":"19:30 EDT","volume":7266,"amount":428769.02,"timestamp":1788391806636,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.735137,"impliedVol":0.6378,"impliedVolPercentile":0.4881},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ELVN\",,,,,undefined,":{"symbol":"ELVN","floatShares":61725902,"roa":"-11.00%","roe":"-15.31%","lyrEps":-1.83,"volumeRatio":0.735137,"shares":73270761,"dividePrice":0,"high":60.55,"amplitude":0.055133,"preClose":57.86,"low":57.36,"week52Low":14.785,"pbRate":"4.83","week52High":62.32,"institutionHeld":0,"latestPrice":59.01,"eps":-1.67535,"divideRate":0,"volume":609969,"delay":0,"ttmEps":-1.67535,"open":58.36,"prevYearClose":15.4,"prevWeekClose":57.86,"prevMonthClose":57.89,"prevQuarterClose":50.75,"fiveDayClose":60.865,"twentyDayClose":59.7,"sixtyDayClose":33.63},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ELVN\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-05","symbol":"ELVN","fiscalQuarterEnding":"2026/06","expectedEps":-0.38,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1785902400000,"reportTimeType":"post","actualEps":-0.49},{"market":"US","date":"2026-05-07","symbol":"ELVN","fiscalQuarterEnding":"2026/03","expectedEps":-0.44,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1778126400000,"reportTimeType":"post","actualEps":-0.38},{"market":"US","date":"2026-03-03","symbol":"ELVN","fiscalQuarterEnding":"2025/12","expectedEps":-0.42,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1772514000000,"reportTimeType":"post","actualEps":-0.48},{"market":"US","date":"2025-11-12","symbol":"ELVN","fiscalQuarterEnding":"2025/09","expectedEps":-0.43,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1762923600000,"reportTimeType":"post","actualEps":-0.32},{"market":"US","date":"2025-08-13","symbol":"ELVN","fiscalQuarterEnding":"2025/06","expectedEps":-0.53,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1755057600000,"reportTimeType":"post","actualEps":-0.49}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ELVN\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ELVN\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.4286,"buy":0.5714,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.5714,"analysts":14,"updateTime":1787112000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/ELVN\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"ELVN","date":"2026-09-01","current":-35.222491,"percent":0.01986,"low":-43.197129,"twenty":-20.738213,"median":-13.157091,"eighty":-10.927793,"high":-6.665619,"avg":-15.743094,"sd":7.233962,"marketCap":4241644354},"quantilePoints":[{"date":"2023-02-24","current":-26.682642,"twenty":-26.682642,"median":-26.682642,"eighty":-26.682642,"marketCap":974023148},{"date":"2023-03-03","current":-24.8289,"twenty":-26.345598,"median":-24.559265,"eighty":-24.199752,"marketCap":906354172},{"date":"2023-03-10","current":-23.694186,"twenty":-25.199648,"median":-24.28963,"eighty":-23.806534,"marketCap":864932556},{"date":"2023-03-17","current":-24.997422,"twenty":-25.053596,"median":-24.508708,"eighty":-23.817768,"marketCap":912505897},{"date":"2023-03-24","current":-25.045524,"twenty":-25.045524,"median":-24.501056,"eighty":-23.817768,"marketCap":943264523},{"date":"2023-03-31","current":-23.847695,"twenty":-25.154418,"median":-24.513309,"eighty":-23.847695,"marketCap":898151871},{"date":"2023-04-06","current":-25.11086,"twenty":-25.119572,"median":-24.513309,"eighty":-23.847695,"marketCap":945725213},{"date":"2023-04-14","current":-20.962015,"twenty":-25.076502,"median":-24.390743,"eighty":-23.811629,"marketCap":789471394},{"date":"2023-04-21","current":-21.332253,"twenty":-25.048753,"median":-24.119928,"eighty":-22.848051,"marketCap":803415304},{"date":"2023-04-28","current":-20.635334,"twenty":-25.016663,"median":-23.926845,"eighty":-21.458569,"marketCap":777167943},{"date":"2023-05-05","current":-20.341321,"twenty":-24.896309,"median":-23.847695,"eighty":-21.260383,"marketCap":766094838},{"date":"2023-05-12","current":-20.851059,"twenty":-24.795534,"median":-23.81078,"eighty":-20.994683,"marketCap":785292584},{"date":"2023-05-19","current":-21.89907,"twenty":-24.705543,"median":-23.593073,"eighty":-21.113722,"marketCap":824762787},{"date":"2023-05-26","current":-21.462399,"twenty":-24.613192,"median":-22.720646,"eighty":-21.211975,"marketCap":808316869},{"date":"2023-06-02","current":-18.734285,"twenty":-24.559265,"median":-21.980633,"eighty":-20.954392,"marketCap":819006716},{"date":"2023-06-09","current":-21.377022,"twenty":-24.515759,"median":-21.83357,"eighty":-20.954392,"marketCap":934539290},{"date":"2023-06-16","current":-18.254642,"twenty":-24.497376,"median":-21.673899,"eighty":-20.758384,"marketCap":798038170},{"date":"2023-06-23","current":-20.812737,"twenty":-24.451411,"median":-21.642525,"eighty":-20.734427,"marketCap":909870413},{"date":"2023-06-30","current":-18.32988,"twenty":-24.28963,"median":-21.616844,"eighty":-20.341321,"marketCap":801327354},{"date":"2023-07-07","current":-17.361189,"twenty":-24.217728,"median":-21.517191,"eighty":-20.09872,"marketCap":758979115},{"date":"2023-07-14","current":-17.135475,"twenty":-24.135893,"median":-21.462399,"eighty":-19.332427,"marketCap":749111564},{"date":"2023-07-21","current":-17.972499,"twenty":-24.119928,"median":-21.435107,"eighty":-18.517975,"marketCap":785703732},{"date":"2023-07-28","current":-16.984999,"twenty":-23.971833,"median":-21.377022,"eighty":-18.220785,"marketCap":742533197},{"date":"2023-08-04","current":-16.881547,"twenty":-23.922067,"median":-21.256028,"eighty":-17.820142,"marketCap":738010570},{"date":"2023-08-11","current":-16.491696,"twenty":-23.861932,"median":-21.016461,"eighty":-17.568094,"marketCap":720967464},{"date":"2023-08-18","current":-12.980214,"twenty":-23.847695,"median":-20.922018,"eighty":-17.248332,"marketCap":669117064},{"date":"2023-08-25","current":-13.578933,"twenty":-23.823753,"median":-20.812737,"eighty":-17.129832,"marketCap":699980398},{"date":"2023-09-01","current":-12.469308,"twenty":-23.815574,"median":-20.736061,"eighty":-17.000046,"marketCap":642780353},{"date":"2023-09-08","current":-12.908368,"twenty":-23.809931,"median":-20.564155,"eighty":-16.862737,"marketCap":665413464},{"date":"2023-09-15","current":-13.123907,"twenty":-23.739125,"median":-20.333094,"eighty":-16.776213,"marketCap":676524264},{"date":"2023-09-22","current":-10.154264,"twenty":-23.633518,"median":-19.996164,"eighty":-15.495828,"marketCap":523442131},{"date":"2023-09-29","current":-10.968521,"twenty":-23.474031,"median":-19.373808,"eighty":-13.527842,"marketCap":565416265},{"date":"2023-10-06","current":-11.511359,"twenty":-23.372472,"median":-19.044642,"eighty":-13.224491,"marketCap":593399020},{"date":"2023-10-13","current":-9.994605,"twenty":-22.593241,"median":-18.52738,"eighty":-13.107941,"marketCap":515211909},{"date":"2023-10-20","current":-10.130315,"twenty":-22.058041,"median":-18.391011,"eighty":-12.999373,"marketCap":522207598},{"date":"2023-10-27","current":-9.555545,"twenty":-22.040989,"median":-18.292261,"eighty":-12.964248,"marketCap":492578798},{"date":"2023-11-03","current":-9.731169,"twenty":-21.920278,"median":-17.972499,"eighty":-12.485274,"marketCap":501632043},{"date":"2023-11-10","current":-7.695346,"twenty":-21.89907,"median":-17.817321,"eighty":-12.245786,"marketCap":475295332},{"date":"2023-11-17","current":-6.952736,"twenty":-21.83357,"median":-17.803213,"eighty":-11.215991,"marketCap":429428758},{"date":"2023-11-24","current":-7.786797,"twenty":-21.720035,"median":-17.492856,"eighty":-10.958941,"marketCap":480943724},{"date":"2023-12-01","current":-7.513225,"twenty":-21.68071,"median":-17.309463,"eighty":-10.760965,"marketCap":464046815},{"date":"2023-12-08","current":-7.506552,"twenty":-21.671453,"median":-17.210713,"eighty":-10.505512,"marketCap":463634696},{"date":"2023-12-15","current":-7.893557,"twenty":-21.652352,"median":-17.121368,"eighty":-10.333081,"marketCap":487537640},{"date":"2023-12-22","current":-8.620858,"twenty":-21.63925,"median":-17.013213,"eighty":-10.031327,"marketCap":532458691},{"date":"2023-12-29","current":-9.721819,"twenty":-21.630859,"median":-16.994403,"eighty":-9.985025,"marketCap":600458446},{"date":"2024-01-05","current":-9.735164,"twenty":-21.621546,"median":-16.919166,"eighty":-9.908649,"marketCap":601282686},{"date":"2024-01-12","current":-7.653347,"twenty":-21.612141,"median":-16.825118,"eighty":-9.735164,"marketCap":472701330},{"date":"2024-01-19","current":-8.547461,"twenty":-21.544748,"median":-16.787499,"eighty":-9.657763,"marketCap":527925374},{"date":"2024-01-26","current":-10.90285,"twenty":-21.510766,"median":-16.702856,"eighty":-9.657763,"marketCap":673403638},{"date":"2024-02-02","current":-10.972911,"twenty":-21.471637,"median":-15.246862,"eighty":-9.711143,"marketCap":677730895},{"date":"2024-02-09","current":-10.282309,"twenty":-21.462504,"median":-13.618847,"eighty":-9.729299,"marketCap":635076503},{"date":"2024-02-16","current":-11.543409,"twenty":-21.454109,"median":-13.399317,"eighty":-9.734365,"marketCap":712967132},{"date":"2024-02-23","current":-10.609261,"twenty":-21.445153,"median":-13.291548,"eighty":-9.761506,"marketCap":655270370},{"date":"2024-03-01","current":-10.655968,"twenty":-21.434015,"median":-13.147855,"eighty":-9.803015,"marketCap":658155208},{"date":"2024-03-08","current":-10.275636,"twenty":-21.409359,"median":-13.10395,"eighty":-9.82474,"marketCap":634664384},{"date":"2024-03-15","current":-6.665619,"twenty":-21.384546,"median":-13.044078,"eighty":-9.733566,"marketCap":477151673},{"date":"2024-03-22","current":-10.431636,"twenty":-21.350161,"median":-12.972231,"eighty":-9.727429,"marketCap":746738233},{"date":"2024-03-28","current":-10.760874,"twenty":-21.310474,"median":-12.880428,"eighty":-9.732767,"marketCap":770306384},{"date":"2024-04-05","current":-12.135517,"twenty":-21.260383,"median":-12.485274,"eighty":-9.752725,"marketCap":868708833},{"date":"2024-04-12","current":-15.541291,"twenty":-21.211975,"median":-12.53879,"eighty":-9.795033,"marketCap":1112507764},{"date":"2024-04-19","current":-11.553574,"twenty":-21.113722,"median":-12.520461,"eighty":-9.82282,"marketCap":827051011},{"date":"2024-04-26","current":-10.971645,"twenty":-20.994683,"median":-12.453342,"eighty":-9.833917,"marketCap":785394226},{"date":"2024-05-03","current":-13.724364,"twenty":-20.956933,"median":-12.42141,"eighty":-9.861485,"marketCap":982444863},{"date":"2024-05-10","current":-15.627075,"twenty":-20.927476,"median":-12.477291,"eighty":-9.897956,"marketCap":1118648510},{"date":"2024-05-17","current":-14.069999,"twenty":-20.877259,"median":-12.55712,"eighty":-9.908649,"marketCap":1119943779},{"date":"2024-05-24","current":-13.579529,"twenty":-20.83573,"median":-12.880428,"eighty":-9.913987,"marketCap":1080903320},{"date":"2024-05-31","current":-13.31952,"twenty":-20.807747,"median":-12.919935,"eighty":-9.925997,"marketCap":1060207172},{"date":"2024-06-07","current":-11.936748,"twenty":-20.777985,"median":-12.852488,"eighty":-9.949337,"marketCap":950141299},{"date":"2024-06-14","current":-13.012238,"twenty":-20.738783,"median":-12.908368,"eighty":-9.978639,"marketCap":1035748089},{"date":"2024-06-21","current":-12.433128,"twenty":-20.734427,"median":-12.823141,"eighty":-9.991412,"marketCap":989652125},{"date":"2024-06-28","current":-13.857265,"twenty":-20.713737,"median":-12.852488,"eighty":-9.999395,"marketCap":1103010568},{"date":"2024-07-05","current":-12.734501,"twenty":-20.635334,"median":-12.852488,"eighty":-10.018554,"marketCap":1013640841},{"date":"2024-07-12","current":-14.217731,"twenty":-20.492975,"median":-12.947875,"eighty":-10.03452,"marketCap":1131702953},{"date":"2024-07-15","current":-14.619562,"twenty":-20.462644,"median":-12.964248,"eighty":-10.034701,"marketCap":1163687908},{"date":"2024-08-02","current":-14.595925,"twenty":-20.432313,"median":-12.972231,"eighty":-10.034882,"marketCap":1161806440},{"date":"2024-08-09","current":-12.834959,"twenty":-20.33803,"median":-12.964248,"eighty":-10.054109,"marketCap":1021637080},{"date":"2024-08-16","current":-13.556309,"twenty":-20.306761,"median":-12.945278,"eighty":-10.088634,"marketCap":1122828410},{"date":"2024-08-23","current":-13.060138,"twenty":-20.227193,"median":-12.964248,"eighty":-10.111156,"marketCap":1081732040},{"date":"2024-08-30","current":-12.672326,"twenty":-20.030349,"median":-12.961651,"eighty":-10.130701,"marketCap":1049610739},{"date":"2024-09-06","current":-12.495529,"twenty":-19.786892,"median":-12.919935,"eighty":-10.135876,"marketCap":1034967205},{"date":"2024-09-13","current":-12.73506,"twenty":-19.581572,"median":-12.931502,"eighty":-10.154517,"marketCap":1054806832},{"date":"2024-09-20","current":-13.157091,"twenty":-19.368165,"median":-12.8873,"eighty":-10.156457,"marketCap":1089762365},{"date":"2024-09-27","current":-13.755918,"twenty":-19.332427,"median":-12.959054,"eighty":-10.16247,"marketCap":1139361432},{"date":"2024-10-04","current":-14.548651,"twenty":-19.185713,"median":-12.995005,"eighty":-10.191351,"marketCap":1205021150},{"date":"2024-10-11","current":-15.381306,"twenty":-18.794475,"median":-13.012238,"eighty":-10.271051,"marketCap":1273987472},{"date":"2024-10-18","current":-15.980134,"twenty":-18.692904,"median":-13.06278,"eighty":-10.276971,"marketCap":1323586540},{"date":"2024-10-25","current":-16.527633,"twenty":-18.517975,"median":-13.077247,"eighty":-10.282309,"marketCap":1368934258},{"date":"2024-10-31","current":-16.191149,"twenty":-18.480356,"median":-13.117169,"eighty":-10.282309,"marketCap":1341064306},{"date":"2024-11-08","current":-16.539039,"twenty":-18.452142,"median":-13.127899,"eighty":-10.308998,"marketCap":1369879003},{"date":"2024-11-15","current":-14.288385,"twenty":-18.32988,"median":-13.147855,"eighty":-10.377785,"marketCap":1217570416},{"date":"2024-11-22","current":-14.569336,"twenty":-18.254642,"median":-13.191309,"eighty":-10.377785,"marketCap":1241511408},{"date":"2024-11-29","current":-13.978765,"twenty":-18.119213,"median":-13.257473,"eighty":-10.420866,"marketCap":1191186467},{"date":"2024-12-06","current":-13.330857,"twenty":-17.99507,"median":-13.275582,"eighty":-10.465191,"marketCap":1135975609},{"date":"2024-12-13","current":-13.187514,"twenty":-17.927356,"median":-13.313517,"eighty":-10.47358,"marketCap":1123760818},{"date":"2024-12-20","current":-13.112976,"twenty":-17.840832,"median":-13.307514,"eighty":-10.475365,"marketCap":1117409126},{"date":"2024-12-27","current":-13.021237,"twenty":-17.81638,"median":-13.27352,"eighty":-10.487821,"marketCap":1109591659},{"date":"2025-01-03","current":-13.703547,"twenty":-17.808856,"median":-13.27352,"eighty":-10.502895,"marketCap":1167734067},{"date":"2025-01-10","current":-13.84689,"twenty":-17.803213,"median":-13.275582,"eighty":-10.521478,"marketCap":1179948858},{"date":"2025-01-17","current":-12.60841,"twenty":-17.759951,"median":-13.27352,"eighty":-10.564579,"marketCap":1074413060},{"date":"2025-01-24","current":-12.637079,"twenty":-17.586904,"median":-13.268745,"eighty":-10.609261,"marketCap":1076856018},{"date":"2025-01-31","current":-12.195584,"twenty":-17.492856,"median":-13.225528,"eighty":-10.642623,"marketCap":1039234460},{"date":"2025-02-07","current":-12.883628,"twenty":-17.445832,"median":-13.157091,"eighty":-10.649204,"marketCap":1097865460},{"date":"2025-02-14","current":-12.327459,"twenty":-17.361189,"median":-13.147855,"eighty":-10.655968,"marketCap":1050472069},{"date":"2025-02-21","current":-12.310258,"twenty":-17.278427,"median":-13.123907,"eighty":-10.661306,"marketCap":1049006294},{"date":"2025-02-28","current":-11.553409,"twenty":-17.220118,"median":-13.115073,"eighty":-10.671914,"marketCap":984512194},{"date":"2025-03-07","current":-12.304524,"twenty":-17.210713,"median":-13.077247,"eighty":-10.692528,"marketCap":1048517702},{"date":"2025-03-14","current":-11.168896,"twenty":-17.203189,"median":-13.06278,"eighty":-10.70156,"marketCap":994299783},{"date":"2025-03-21","current":-11.515688,"twenty":-17.148642,"median":-13.044078,"eighty":-10.73075,"marketCap":1025172571},{"date":"2025-03-28","current":-11.840461,"twenty":-17.112904,"median":-13.012192,"eighty":-10.756253,"marketCap":1054085181},{"date":"2025-04-04","current":-11.025775,"twenty":-17.062118,"median":-12.992568,"eighty":-10.756253,"marketCap":981558632},{"date":"2025-04-11","current":-8.207404,"twenty":-17.020737,"median":-12.961651,"eighty":-10.671914,"marketCap":730655976},{"date":"2025-04-17","current":-8.845942,"twenty":-17.00757,"median":-12.919935,"eighty":-10.646572,"marketCap":787501109},{"date":"2025-04-25","current":-10.073474,"twenty":-16.992523,"median":-12.900829,"eighty":-10.506428,"marketCap":896780977},{"date":"2025-05-02","current":-10.926692,"twenty":-16.945499,"median":-12.87493,"eighty":-10.47358,"marketCap":972737836},{"date":"2025-05-09","current":-10.268015,"twenty":-16.896595,"median":-12.837758,"eighty":-10.456802,"marketCap":914099729},{"date":"2025-05-16","current":-9.22086,"twenty":-16.864245,"median":-12.824716,"eighty":-10.419165,"marketCap":874414177},{"date":"2025-05-23","current":-8.677544,"twenty":-16.841798,"median":-12.774982,"eighty":-10.35027,"marketCap":822891456},{"date":"2025-05-30","current":-9.179465,"twenty":-16.826999,"median":-12.740411,"eighty":-10.284647,"marketCap":870488636},{"date":"2025-06-06","current":-11.057788,"twenty":-16.804427,"median":-12.734501,"eighty":-10.282309,"marketCap":1048610043},{"date":"2025-06-13","current":-10.172958,"twenty":-16.787499,"median":-12.717951,"eighty":-10.278305,"marketCap":964701612},{"date":"2025-06-20","current":-13.417901,"twenty":-16.781856,"median":-12.734501,"eighty":-10.282309,"marketCap":1272419584},{"date":"2025-06-27","current":-13.386798,"twenty":-16.747999,"median":-12.73478,"eighty":-10.283478,"marketCap":1269470072},{"date":"2025-07-03","current":-12.895368,"twenty":-16.702856,"median":-12.73478,"eighty":-10.288155,"marketCap":1222867778},{"date":"2025-07-11","current":-14.170598,"twenty":-16.684047,"median":-12.73506,"eighty":-10.29197,"marketCap":1343797781},{"date":"2025-07-18","current":-14.518953,"twenty":-16.539039,"median":-12.769279,"eighty":-10.308998,"marketCap":1376832318},{"date":"2025-07-25","current":-13.654285,"twenty":-16.539039,"median":-12.823141,"eighty":-10.377785,"marketCap":1294835877},{"date":"2025-08-01","current":-11.701007,"twenty":-16.527633,"median":-12.814277,"eighty":-10.377785,"marketCap":1109606508},{"date":"2025-08-08","current":-11.13493,"twenty":-16.527633,"median":-12.763576,"eighty":-10.392743,"marketCap":1055925385},{"date":"2025-08-15","current":-11.683894,"twenty":-16.52193,"median":-12.73478,"eighty":-10.409257,"marketCap":1170901400},{"date":"2025-08-22","current":-11.727119,"twenty":-16.516227,"median":-12.729357,"eighty":-10.425771,"marketCap":1175233252},{"date":"2025-08-29","current":-12.034483,"twenty":-16.491696,"median":-12.666623,"eighty":-10.431636,"marketCap":1206035736},{"date":"2025-09-05","current":-11.827604,"twenty":-16.470258,"median":-12.655877,"eighty":-10.465191,"marketCap":1185303295},{"date":"2025-09-12","current":-11.774406,"twenty":-16.437524,"median":-12.642812,"eighty":-10.47358,"marketCap":1179972096},{"date":"2025-09-19","current":-11.777361,"twenty":-16.362242,"median":-12.617902,"eighty":-10.475365,"marketCap":1180268273},{"date":"2025-09-26","current":-10.976442,"twenty":-16.281259,"median":-12.614144,"eighty":-10.477125,"marketCap":1100004107},{"date":"2025-10-03","current":-11.774406,"twenty":-16.205977,"median":-12.604497,"eighty":-10.492153,"marketCap":1179972096},{"date":"2025-10-10","current":-12.584192,"twenty":-16.158355,"median":-12.584192,"eighty":-10.509962,"marketCap":1261124795},{"date":"2025-10-17","current":-12.856091,"twenty":-16.100826,"median":-12.570656,"eighty":-10.522555,"marketCap":1288373147},{"date":"2025-10-24","current":-12.146789,"twenty":-16.047431,"median":-12.55712,"eighty":-10.547691,"marketCap":1217290490},{"date":"2025-10-31","current":-14.168299,"twenty":-16.017711,"median":-12.59139,"eighty":-10.598091,"marketCap":1419876061},{"date":"2025-11-07","current":-10.816849,"twenty":-16.012848,"median":-12.55712,"eighty":-10.635951,"marketCap":1084010510},{"date":"2025-11-14","current":-12.003893,"twenty":-15.986677,"median":-12.54534,"eighty":-10.635951,"marketCap":1202970115},{"date":"2025-11-21","current":-12.98587,"twenty":-15.975572,"median":-12.55712,"eighty":-10.647888,"marketCap":1262317432},{"date":"2025-11-28","current":-13.187343,"twenty":-15.974431,"median":-12.598588,"eighty":-10.653262,"marketCap":1281902047},{"date":"2025-12-05","current":-13.065238,"twenty":-15.940212,"median":-12.601543,"eighty":-10.659972,"marketCap":1270032583},{"date":"2025-12-12","current":-11.459557,"twenty":-15.886602,"median":-12.584192,"eighty":-10.669596,"marketCap":1113949140},{"date":"2025-12-19","current":-10.183559,"twenty":-15.842118,"median":-12.556807,"eighty":-10.629278,"marketCap":989913247},{"date":"2025-12-26","current":-10.214086,"twenty":-15.803337,"median":-12.543135,"eighty":-10.536256,"marketCap":992880613},{"date":"2026-01-02","current":-9.402087,"twenty":-15.766837,"median":-12.530924,"eighty":-10.485339,"marketCap":913948681},{"date":"2026-01-09","current":-14.194709,"twenty":-15.757712,"median":-12.525083,"eighty":-10.474026,"marketCap":1379825120},{"date":"2026-01-16","current":-15.366918,"twenty":-15.766837,"median":-12.533872,"eighty":-10.476139,"marketCap":1493771968},{"date":"2026-01-23","current":-16.502494,"twenty":-15.873654,"median":-12.554602,"eighty":-10.477453,"marketCap":1604157978},{"date":"2026-01-30","current":-15.67218,"twenty":-15.873654,"median":-12.55712,"eighty":-10.482717,"marketCap":1523445627},{"date":"2026-02-06","current":-16.478073,"twenty":-15.974431,"median":-12.601543,"eighty":-10.495828,"marketCap":1601784085},{"date":"2026-02-13","current":-16.581863,"twenty":-16.012848,"median":-12.60841,"eighty":-10.513495,"marketCap":1611873129},{"date":"2026-02-20","current":-15.971338,"twenty":-16.047431,"median":-12.614144,"eighty":-10.522555,"marketCap":1552525812},{"date":"2026-02-27","current":-18.083755,"twenty":-16.148743,"median":-12.62937,"eighty":-10.547691,"marketCap":1757867529},{"date":"2026-03-06","current":-16.891565,"twenty":-16.308347,"median":-12.642812,"eighty":-10.598091,"marketCap":1751553891},{"date":"2026-03-13","current":-16.614748,"twenty":-16.467534,"median":-12.654701,"eighty":-10.635951,"marketCap":1722849696},{"date":"2026-03-20","current":-17.329857,"twenty":-16.467534,"median":-12.66092,"eighty":-10.647888,"marketCap":1797002200},{"date":"2026-03-27","current":-22.658572,"twenty":-16.515009,"median":-12.723654,"eighty":-10.654615,"marketCap":2349557951},{"date":"2026-04-02","current":-21.793521,"twenty":-16.527633,"median":-12.734501,"eighty":-10.659972,"marketCap":2259857342},{"date":"2026-04-10","current":-26.291786,"twenty":-16.580833,"median":-12.737874,"eighty":-10.669596,"marketCap":2726300509},{"date":"2026-04-17","current":-26.147611,"twenty":-16.691571,"median":-12.769279,"eighty":-10.687954,"marketCap":2711350408},{"date":"2026-04-24","current":-25.311395,"twenty":-16.770571,"median":-12.821028,"eighty":-10.700446,"marketCap":2624639819},{"date":"2026-05-01","current":-23.777371,"twenty":-16.840911,"median":-12.830625,"eighty":-10.720149,"marketCap":2465570739},{"date":"2026-05-08","current":-23.660577,"twenty":-16.902605,"median":-12.844269,"eighty":-10.735381,"marketCap":2453459912},{"date":"2026-05-15","current":-26.562713,"twenty":-16.992523,"median":-12.857068,"eighty":-10.751632,"marketCap":2623785073},{"date":"2026-05-22","current":-26.050943,"twenty":-17.071504,"median":-12.866232,"eighty":-10.770508,"marketCap":2573233968},{"date":"2026-05-29","current":-25.064398,"twenty":-17.140318,"median":-12.883628,"eighty":-10.779257,"marketCap":2475786054},{"date":"2026-06-05","current":-21.882792,"twenty":-17.206951,"median":-12.898098,"eighty":-10.796387,"marketCap":2161516533},{"date":"2026-06-12","current":-24.885587,"twenty":-17.289838,"median":-12.908368,"eighty":-10.823355,"marketCap":2458123620},{"date":"2026-06-18","current":-27.660244,"twenty":-17.423782,"median":-12.959054,"eighty":-10.834214,"marketCap":2732195877},{"date":"2026-06-26","current":-30.286918,"twenty":-17.681151,"median":-12.983042,"eighty":-10.842708,"marketCap":2991650947},{"date":"2026-07-02","current":-34.467224,"twenty":-17.803213,"median":-13.001182,"eighty":-10.859067,"marketCap":3404568943},{"date":"2026-07-10","current":-36.884736,"twenty":-17.91607,"median":-13.012238,"eighty":-10.862815,"marketCap":3643363566},{"date":"2026-07-17","current":-35.951661,"twenty":-18.010492,"median":-13.044125,"eighty":-10.872726,"marketCap":3551197220},{"date":"2026-07-24","current":-37.330067,"twenty":-18.254642,"median":-13.065238,"eighty":-10.89369,"marketCap":3687352049},{"date":"2026-07-31","current":-38.135905,"twenty":-18.489761,"median":-13.068026,"eighty":-10.901018,"marketCap":3766950256},{"date":"2026-08-07","current":-39.727657,"twenty":-19.292928,"median":-13.08062,"eighty":-10.904296,"marketCap":4208231547},{"date":"2026-08-14","current":-40.16068,"twenty":-19.893608,"median":-13.117169,"eighty":-10.914394,"marketCap":4254100383},{"date":"2026-08-21","current":-40.755551,"twenty":-20.371092,"median":-13.127899,"eighty":-10.919864,"marketCap":4317113238},{"date":"2026-08-28","current":-41.848453,"twenty":-20.733857,"median":-13.147855,"eighty":-10.925478,"marketCap":4432881040},{"date":"2026-09-01","current":-40.04309,"twenty":-20.738213,"median":-13.157091,"eighty":-10.927793,"marketCap":4241644354}],"updateTime":1788401400623},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ELVN\",pageSize:20,pageCount:4,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2642450257","title":"U.S. RESEARCH ROUNDUP- Apple, Lennar, Toll Brothers","url":"https://stock-news.laohu8.com/highlight/detail?id=2642450257","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642450257?lang=en_us&edition=fundamental","pubTime":"2026-06-09 15:46","pubTimestamp":1780991198,"startTime":"0","endTime":"0","summary":"U.S. RESEARCH ROUNDUP- Apple, Lennar, Toll Brothers June 9 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Apple, Lennar","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260609:nL4N42H0KJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AAPL","CAR","CPB","FFIV","CDNS","AAPU","APLX","AAPY","GOOG","TOL","ULTA","EQR","APLD","LMND","GMRS","BRO","USJW.SI","AAPW","DEO","FVR","ELVN","ECL","GHM","MTN","PODD","APLZ","EROK","AAPB","BBUC","BWIN","FICO","LMNX","ODFL","ZVRA","CLF","PAR","TNGX","AAPD","DXCM","AJG","LEN","AU","GPN","ARCB","ATO","PFS","LOPE","AAPX","DGE.UK","GSHD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642243142","title":"Enliven initiated with a Buy at Stifel","url":"https://stock-news.laohu8.com/highlight/detail?id=2642243142","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642243142?lang=en_us&edition=fundamental","pubTime":"2026-06-09 04:18","pubTimestamp":1780949906,"startTime":"0","endTime":"0","summary":"Stifel initiated coverage of Enliven (ELVN) with a Buy rating and $60 price target The company’s ELVN-001 is “uniquely positioned” as a complement ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/enliven-initiated-with-a-buy-at-stifel-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/enliven-initiated-with-a-buy-at-stifel-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4127","ELVN","BK4007","SF"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640915045","title":"Mizuho Securities Sticks to Their Buy Rating for Enliven Therapeutics (ELVN)","url":"https://stock-news.laohu8.com/highlight/detail?id=2640915045","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640915045?lang=en_us&edition=fundamental","pubTime":"2026-06-02 16:36","pubTimestamp":1780389371,"startTime":"0","endTime":"0","summary":"In a report released today, Salim Syed from Mizuho Securities maintained a Buy rating on Enliven Therapeutics, with a price target of $62.00. Accor...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/mizuho-securities-sticks-to-their-buy-rating-for-enliven-therapeutics-elvn-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/mizuho-securities-sticks-to-their-buy-rating-for-enliven-therapeutics-elvn-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LENZ","ELVN","MFG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637035173","title":"Enliven Therapeutics presents at TD Cowen oncology summit fireside chat","url":"https://stock-news.laohu8.com/highlight/detail?id=2637035173","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637035173?lang=en_us&edition=fundamental","pubTime":"2026-05-22 04:07","pubTimestamp":1779394032,"startTime":"0","endTime":"0","summary":"Enliven Therapeutics management is scheduled to participate in a fireside chat at TD Cowen’s Annual Oncology Innovation Summit on May 27 at 2:30 p.m. ET.Another fireside chat is set for the Jefferies Global Healthcare Conference on June 4 at 11:40 a.m. ET.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Enliven Therapeutics Inc. published the original content used to generate this news brief via PR Newswire  on May 21, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260521:nNDLgYKKs:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ELVN","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637878760","title":"Enliven CMO Helen Louise Collins sells USD 191,757 in common shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2637878760","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637878760?lang=en_us&edition=fundamental","pubTime":"2026-05-21 04:19","pubTimestamp":1779308372,"startTime":"0","endTime":"0","summary":"Enliven Therapeutics Chief Medical Officer Helen Louise Collins exercised stock options for 5,000 shares at USD 2.48 on May 18, 2026.Collins sold 5,000 shares the same day for weighted average prices of about USD 39.53 to USD 41.21.Holdings reported as 25,000 shares following the transactions.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Enliven Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 20, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260520:nNDL9jrZdV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Enliven CMO Helen Louise Collins sells USD 191,757 in common shares","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","ELVN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635706652","title":"Analysts Are Bullish on Top Healthcare Stocks: Molecular Partners (MOLN), Enliven Therapeutics (ELVN)","url":"https://stock-news.laohu8.com/highlight/detail?id=2635706652","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635706652?lang=en_us&edition=fundamental","pubTime":"2026-05-16 22:40","pubTimestamp":1778942410,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Molecular Partners (MOLN), Enliven Therapeutics (ELV...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-top-healthcare-stocks-molecular-partners-moln-enliven-therapeutics-elvn-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-top-healthcare-stocks-molecular-partners-moln-enliven-therapeutics-elvn-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","BK4588","LU0029874061.USD","BK4581","MOLN","BLSG","XBI","LABU","ELVN","BK4139","BK4137","BK4585","BK4112","BK4539","LU0128526141.USD","BLSX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635867242","title":"Enliven to presents Phase 1 clinical trial data for ELVN-100 at EHA Congress","url":"https://stock-news.laohu8.com/highlight/detail?id=2635867242","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635867242?lang=en_us&edition=fundamental","pubTime":"2026-05-13 03:08","pubTimestamp":1778612889,"startTime":"0","endTime":"0","summary":"Enliven (ELVN) Therapeutics announced additional data from the Phase 1 ENABLE clinical trial evaluating ELVN-001 in patients with chronic myeloid l...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/enliven-to-presents-phase-1-clinical-trial-data-for-elvn-100-at-eha-congress-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/enliven-to-presents-phase-1-clinical-trial-data-for-elvn-100-at-eha-congress-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ELVN","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1150376332","title":"Stock Track | Enliven Therapeutics Soars 5.35% on Positive Clinical Data, Analyst Initiation, and Earnings Beat","url":"https://stock-news.laohu8.com/highlight/detail?id=1150376332","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1150376332?lang=en_us&edition=fundamental","pubTime":"2026-05-12 23:09","pubTimestamp":1778598546,"startTime":"0","endTime":"0","summary":"Enliven Therapeutics' stock soared 5.35% during intraday trading on Tuesday, driven by a confluence of positive developments for the biotechnology company.The surge follows the announcement of...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["ELVN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634294217","title":"Enliven presents updated Phase 1 ELVN-001 data in CML at EHA 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2634294217","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634294217?lang=en_us&edition=fundamental","pubTime":"2026-05-12 21:54","pubTimestamp":1778594047,"startTime":"0","endTime":"0","summary":"Enliven Therapeutics flagged additional positive Phase 1 data for ELVN-001 in previously treated chronic myeloid leukemia, with updated results scheduled for oral presentation at EHA 2026 on June 11.Some findings were already presented in January 2026, with new disclosures set to extend follow-up and add patients.ELVN-001 continued to show meaningful anti-disease activity in a heavily pretreated population, including patients previously treated with asciminib.Safety profile remained favorable, with most patients staying on therapy and relatively few stopping treatment due to side effects.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260512:nNDLbfcRMj:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ELVN","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634217237","title":"Enliven Therapeutics Announces Oral Presentation at the Eha 2026 Congress Featuring Additional Positive Phase 1 Clinical Trial Data for Elvn-001 in Cml","url":"https://stock-news.laohu8.com/highlight/detail?id=2634217237","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634217237?lang=en_us&edition=fundamental","pubTime":"2026-05-12 21:53","pubTimestamp":1778594030,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260512:nTUAVN836:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","ELVN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634169752","title":"Enliven Therapeutics Inc reports results for the quarter ended March 31 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2634169752","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634169752?lang=en_us&edition=fundamental","pubTime":"2026-05-12 19:59","pubTimestamp":1778587190,"startTime":"0","endTime":"0","summary":"Enliven Therapeutics Inc reports results for the quarter ended March 31 - Earnings SummaryEnliven Therapeutics Inc ELVN.OQ reported a quarterly adjusted loss of 38 cents per share for the quarter ende","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260512:nL8N41P1LQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ELVN","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634298415","title":"U.S. RESEARCH ROUNDUP-Accuray, Aevex, Zoetis","url":"https://stock-news.laohu8.com/highlight/detail?id=2634298415","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634298415?lang=en_us&edition=fundamental","pubTime":"2026-05-12 15:21","pubTimestamp":1778570494,"startTime":"0","endTime":"0","summary":"U.S. RESEARCH ROUNDUP-Accuray, Aevex, ZoetisMay 12 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Accuray, Aevex and Zo","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260512:nL4N41P0LT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BILL","HIMS","AMAT","HIMY","FTV","BK4216","TRGP","APO","HMYY","CE","SIBN","SKYE","TXG","BAM","LU0106831901.USD","LU0476273544.USD","MOS","CYTK","PLNT","PSIX","SPG","KKR","SNDA","VCTR","VSNT","BK4106","GTM","LQDA","LU0345781412.USD","BX","ALMR","CGNX","CVS","LENZ","AGM","LU2089985449.USD","TGT","CEVA","TOST","HIMZ","LU2458330169.SGD","ELVN","SGI","AVEX","HIYY","WPC","ARES","ZTS","ARAY","ASTH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634853268","title":"Enliven Therapeutics Inc : Guggenheim Initiates Coverage With Buy Rating; Target Price $80","url":"https://stock-news.laohu8.com/highlight/detail?id=2634853268","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634853268?lang=en_us&edition=fundamental","pubTime":"2026-05-12 11:11","pubTimestamp":1778555518,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260512:nFWN41P05R:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","ELVN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634251756","title":"Enliven initiated with a Buy at Guggenheim","url":"https://stock-news.laohu8.com/highlight/detail?id=2634251756","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634251756?lang=en_us&edition=fundamental","pubTime":"2026-05-12 08:30","pubTimestamp":1778545809,"startTime":"0","endTime":"0","summary":"Guggenheim initiated coverage of Enliven (ELVN) with a Buy rating and $80 price target Published first on TheFly – the ultimate source for real-tim...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/enliven-initiated-with-a-buy-at-guggenheim-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/enliven-initiated-with-a-buy-at-guggenheim-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ELVN","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634146961","title":"Enliven price target raised to $59 from $41 at Goldman Sachs","url":"https://stock-news.laohu8.com/highlight/detail?id=2634146961","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634146961?lang=en_us&edition=fundamental","pubTime":"2026-05-09 02:30","pubTimestamp":1778265031,"startTime":"0","endTime":"0","summary":"Goldman Sachs raised the firm’s price target on Enliven (ELVN) to $59 from $41 and keeps a Buy rating on the shares. Enliven reported Q1 results an...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/enliven-price-target-raised-to-59-from-41-at-goldman-sachs-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/enliven-price-target-raised-to-59-from-41-at-goldman-sachs-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0096364046.USD","BK4533","GSX","BK4552","BK4007","BK4127","LU0742534661.SGD","IE00B19Z3B42.SGD","LU2237443622.USD","LU2237443895.HKD","LU2471134879.HKD","LU2750360641.GBP","LU2237443465.HKD","LU1868836591.USD","LU0345770308.USD","LU2237443549.SGD","LU1894683264.USD","IE0034235188.USD","IE00BFXG1179.USD","IE00BSNM7G36.USD","LU2237443382.USD","LU1804176565.USD","IE0004091025.USD","ELVN","LU1868836914.USD","LU2471134952.CNY","LU2471134523.USD","BK4585","LU2237443978.SGD","IE0004086264.USD","BK4504","LU2471134796.USD","LU1868837300.USD","LU1868836757.USD","BK4550","IE0002270589.USD","LU2750360997.AUD","LU1791807156.HKD","BK4588","LU0345770993.USD","LU0048573561.USD","IE00B19Z3581.USD","BK4516","LU2265009873.SGD","LU1668664300.SGD","LU2237438978.USD","LU1868837136.USD","LU0251131958.USD","LU0061475181.USD","LU0106831901.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633455924","title":"Phil Nadeau Reiterates Buy on Enliven, Citing Strong ELVN-001 Early Data, Clear Pivotal Path, and Solid Cash Runway to 2029","url":"https://stock-news.laohu8.com/highlight/detail?id=2633455924","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633455924?lang=en_us&edition=fundamental","pubTime":"2026-05-08 19:55","pubTimestamp":1778241351,"startTime":"0","endTime":"0","summary":"TD Cowen analyst Phil Nadeau has maintained their bullish stance on ELVN stock, giving a Buy rating yesterday. Phil Nadeau has given his Buy rating...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/phil-nadeau-reiterates-buy-on-enliven-citing-strong-elvn-001-early-data-clear-pivotal-path-and-solid-cash-runway-to-2029-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/phil-nadeau-reiterates-buy-on-enliven-citing-strong-elvn-001-early-data-clear-pivotal-path-and-solid-cash-runway-to-2029-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ELVN","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633106883","title":"Needham’s Boris Peaker Reiterates Buy on Enliven, Citing Strong ELVN-001 Efficacy in CML and Pivotal Phase 3 ENABLE-2 Catalyst Pathway","url":"https://stock-news.laohu8.com/highlight/detail?id=2633106883","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633106883?lang=en_us&edition=fundamental","pubTime":"2026-05-08 07:15","pubTimestamp":1778195720,"startTime":"0","endTime":"0","summary":"JonesTrading analyst Boris Peaker has maintained their bullish stance on ELVN stock, giving a Buy rating on April 27. Boris Peaker has given his Bu...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/needhams-boris-peaker-reiterates-buy-on-enliven-citing-strong-elvn-001-efficacy-in-cml-and-pivotal-phase-3-enable-2-catalyst-pathway-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/needhams-boris-peaker-reiterates-buy-on-enliven-citing-strong-elvn-001-efficacy-in-cml-and-pivotal-phase-3-enable-2-catalyst-pathway-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ELVN","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633703881","title":"Enliven Therapeutics Q1 net loss narrows as R&D spending reduces","url":"https://stock-news.laohu8.com/highlight/detail?id=2633703881","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633703881?lang=en_us&edition=fundamental","pubTime":"2026-05-08 05:12","pubTimestamp":1778188365,"startTime":"0","endTime":"0","summary":"Enliven Therapeutics Q1 net loss narrows as R&D spending reducesOverviewUS biopharma firm's Q1 net loss narrowed year-over-year as R&D expenses declinedOperating expenses for Q1 decreased compared to ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260507:nL1N41K1M1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ELVN","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633174687","title":"Enliven Q1 FY26 net loss narrows to $23.6 million###","url":"https://stock-news.laohu8.com/highlight/detail?id=2633174687","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633174687?lang=en_us&edition=fundamental","pubTime":"2026-05-08 04:29","pubTimestamp":1778185778,"startTime":"0","endTime":"0","summary":"Enliven Therapeutics posted a net loss of USD 23.6 million, narrowing from USD 28.5 million a year earlier, while R&D expense fell to USD 20.7 million from USD 24.9 million.Operating loss narrowed to USD 27.8 million from USD 31.7 million, while G&A expense rose to USD 7.1 million from USD 6.8 million.Cash, cash equivalents and marketable securities totaled USD 452.4 million at March 31, down from USD 462.6 million at end-2025, providing runway into first half of 2029.Phase 1 data update for ELVN-001 expected mid-2026, with Phase 3 ENABLE-2 initiation expected in second half of 2026 alongside FDA interactions on dose selection and trial design.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260507:nNDL3269sC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ELVN","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633796461","title":"Press Release: Enliven Therapeutics Reports First Quarter Financial Results and Provides a Business Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2633796461","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633796461?lang=en_us&edition=fundamental","pubTime":"2026-05-08 04:05","pubTimestamp":1778184300,"startTime":"0","endTime":"0","summary":"Phase 1 data update for ELVN-001 expected mid-2026. Initiation of the Phase 3 ENABLE-2 pivotal trial of ELVN-001 expected in the second half of 2026. Strong balance sheet with $452 million in cash, cash equivalents and marketable securities, which is expected to provide cash runway into the first half of 2029. BOULDER, Colo., May 7, 2026 /PRNewswire/ -- Enliven Therapeutics, Inc.  , a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics, today reported financial results for the first quarter ended March 31, 2026, and provided a business update.\"Recent strategic momentum in CML validates a remaining unmet need and a compelling long-term opportunity. Against this backdrop,  we remain focused on execution as we prepare to initiate the Phase 3 pivotal trial of ELVN-001 in the second half of 2026,\" said Rick Fair, Chief Executive Officer of Enliven. \"Based on the Phase 1 data generated to date, we believe ELVN-001 has the potential","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","BK4539","BK4139","ELVN","LENZ"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":5,"pageCount":4,"totalSize":99,"code":"91000000","status":"200"}]}}